World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02751073
Date of registration: 22/02/2016
Prospective Registration: No
Primary sponsor: Mayo Clinic
Public title: Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy
Scientific title: Evaluation of Vaginal and Urinary Microbiome Markers as Predictors of Post-Surgical Urinary Tract Infection
Date of first enrolment: February 2016
Target sample size: 25
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02751073
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     John A Occhino, M.D.
Address: 
Telephone:
Email:
Affiliation:  Mayo Clinic
Key inclusion & exclusion criteria

Inclusion Criteria:

- Postmenopausal females (defined by cessation of menses for one full year)

- Planned surgical correction of pelvic organ prolapse with transvaginal hysterectomy
and concomitant pelvic reconstruction for uterovaginal prolapse

- Scheduled surgery date within 4 weeks of study consent

- Physically able to self-collect vaginal swabs and clean-catch urine samples

Exclusion Criteria:

- Women who are premenopausal, pregnant or nursing

- Currently taking or have taken antibiotics in the past 2 weeks

- History of recurrent urinary tract infections

- History of mesh complications, including erosion/extrusion

- Non-vaginal approach to hysterectomy or prolapse repair



Age minimum: 40 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Urinary Tract Infection
Hysterectomy
Pelvic Organ Prolapse
Intervention(s)
Primary Outcome(s)
Identification of the postoperative urinary tract microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: 12-18 hours after surgery]
Identification of the immediate postoperative vaginal microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within 6 hours of collecting the pre-operative sample]
Identification of the postoperative urinary tract microbiome at least 6 weeks following surgery through DNA extraction and 16S rRNA gene sequencing [Time Frame: 6 weeks (up to 8 weeks)]
Identification of baseline urinary tract microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: 1 day (Pre-operative Urogynecology surgical consultation visit)]
Identification of key biomarkers associated with risk of postoperative urinary tract infection through proteomic mass spectrometry analysis of vaginal swab collected in the setting of postoperative urinary tract infection [Time Frame: Within the first 6 weeks after surgery]
Identification of pre-operative vaginal microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within 4 weeks of baseline sample collected at Urogynecology surgical consultation visit)]
Identification of the postoperative vaginal microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: 12-18 hours after surgery]
Identification of baseline vaginal microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: 1 day (Pre-operative Urogynecology surgical consultation visit)]
Identification of the vaginal microbiome at least 6 weeks following surgery through DNA extraction and 16S rRNA gene sequencing [Time Frame: 6 weeks (up to 8 weeks)]
Identification of the immediate postoperative urinary tract microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within 6 hours of collecting the pre-operative sample]
Identification of urinary tract microbiome in the setting of postoperative urinary tract infection through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within the first 6 weeks after surgery]
Identification of vaginal microbiome in the setting of postoperative urinary tract infection through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within the first 6 weeks after surgery]
Identification of pre-operative urinary tract microbiome through DNA extraction and 16S rRNA gene sequencing [Time Frame: Within 4 weeks of baseline sample collected at Urogynecology surgical consultation visit)]
Secondary Outcome(s)
Secondary ID(s)
15-006300
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history